Recent Healthcare Financings
| Company Name | Amount Raised | Type of Fundraise | Country | Date |
| Private Company Financings | ||||
| Mediar Therapeutics | $76 million | Series B | US | 7 January |
| STRM.BIO | $8 million | Seed round | US | 7 January |
| TECregen | $12.5 million | Seed round | Switzerland | 8 January |
| Enodia | $24.1 million | Seed round | France | 8 January |
| Engitix | $25 million | Series A | UK | 8 January |
| Beacon Therapeutics | $75 million | Series C | US | 8 January |
| RISA Labs | $11.1 million | Series A | US | 13 January |
| Converge Bio | $25 million | Series A | US | 13 January |
| Caldera Therapeutics | $112.5 million | Series A | US | 14 January |
| Think Bioscience | $55 million | Series A | US | 20 January |
| Exciva | $59 million | Series B | Germany | 20 January |
| ErVimmune | $19.8 million | Series A | France | 21 January |
| Mendra | $82 million | Series A | US | 22 January |
| CORXEL | $287 million | Series D | US | 22 January |
| Primmune Therapeutics | $8.6 million | Series B | US | 26 January |
| Tandem | $100 million | N/A | US | 26 January |
| Evaro | $25 million | Series A | UK | 26 January |
| TRex Bio | $50 million | N/A | US | 26 January |
| Public Company Financings | ||||
| Alumis | $300 million | Public offering | US | 7 January |
| Bright Minds Biosciences | $175 million | Public offering | US | 8 January |
| Monte Rosa Therapeutics | $300 million | Public offering | US | 8 January |
| Aktis Oncology | $365.4 million | Public offering | US | 13 January |
| Erasca | $258.8 million | Public Offering | US | 23 January |